Daratumumab and Romiplostim Combined Therapy for a Long-Standing Refractory Primary Immune Thrombocytopenia – Case Report
Ibrahim Zoubi,1 Amir Warwar,1,2 Shoshan Perek,1 Meir Preis1,2 1Institute of Hematology, Lady Davis Carmel Medical Center, Haifa, Israel; 2Bruce and Ruth Rappaport Faculty of Medicine, Technion- Israel Institute of Technology, Haifa, IsraelCorrespondence: Meir Preis, Institute of Hematology, Lady Dav...
Saved in:
Main Authors: | Zoubi I, Warwar A, Perek S, Preis M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2025-01-01
|
Series: | ImmunoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/daratumumab-and-romiplostim-combined-therapy-for-a-long-standing-refra-peer-reviewed-fulltext-article-ITT |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sustained response off treatment after fostamatinib in refractory immune thrombocytopenia: A series of four case reports
by: Waleed Ghanima, et al.
Published: (2025-12-01) -
Correction of Thrombocytopenia before Elective Surgery / Invasive Procedures in Patients with Liver Cirrhosis (Experts’ Agreement)
by: M. V. Maevskaya, et al.
Published: (2024-08-01) -
Observation on the efficacy of TPO receptor agonists and platelet transfusion in chemotherapy-induced thrombocytopenia in malignant tumors
by: Huan Hu, et al.
Published: (2025-01-01) -
Anticoagulant management of cancer-associated thrombosis and thrombocytopenia: a retrospective chart review
by: Umaima Abbas, et al.
Published: (2025-01-01) -
The Effects of Preeclampsia Severity and Thrombocytopenia on the Prognosis of Hypertensive Pregnant Women
by: Emre Beşe, et al.
Published: (2013-04-01)